Welcome to the final episode of season 1!!! In this episode we tackle the following classes: PI3K inhibitors, mTOR inhibitors, Proteosome inhibitors, Histone deacetylase inhibitors, DNA Methylation inhibitors, Hedgehog pathway blockers, and CAR T cell therapy. What an exciting group of target therapies, novel ways to fight cancer that are really fascinating.